Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety

被引:209
作者
Zhu, Ruyuan [1 ]
Liu, Haixia [1 ]
Liu, Chenyue [2 ]
Wang, Lili [1 ]
Ma, Rufeng [1 ]
Chen, Beibei [1 ]
Li, Lin [1 ]
Niu, Jianzhao [1 ]
Fu, Min [3 ]
Zhang, Dongwei [4 ]
Gao, Sihua [4 ]
机构
[1] Beijing Univ Chinese Med, Preclin Med Sch, Beijing 100029, Peoples R China
[2] Beijing Univ Chinese Med, Chinese Mat Med Sch, Beijing 100029, Peoples R China
[3] McGill Univ, Res Inst, Hlth Ctr, Montreal, PQ H4A 3J1, Canada
[4] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
Cinnamaldehyde; Diabetes; Obesity; Pharmacology; Pharmacokinetics; Safety; ADIPOSE-TISSUE INFLAMMATION; HIGH-FAT DIET; STIMULATED INSULIN-SECRETION; FASTING BLOOD-GLUCOSE; TRANS-CINNAMALDEHYDE; CINNAMIC ALDEHYDE; NRF2; ACTIVATORS; PPAR-GAMMA; ANTIOXIDANT ACTIVITY; 3T3-L1; ADIPOCYTES;
D O I
10.1016/j.phrs.2017.05.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cinnamaldehyde, one of the active components derived from Cinnamon, has been used as a natural flavorant and fragrance agent in kitchen and industry. Emerging studies have been performed over the past decades to evaluate its beneficial role in management of diabetes and its complications. This review highlights recent advances of cinnamaldehyde in its glucolipid lowering effects, its pharmacokinetics, and its safety by consulting the Pubmed, China Knowledge Resource Integrated, China Science and Technology Journal, National Science and Technology Library, Wanfang Data, and the Web of Science Databases. For the inquiries, keywords such as Cinnamon, cinnamaldehyde, property, synthesis, diabetes, obesity, pharmacokinetics, and safety were used in various combinations. Accumulating evidence supports the notion that cinnamaldehyde exhibits glucolipid lowering effects in diabetic animals by increasing glucose uptake and improving insulin sensitivity in adipose and skeletal muscle tissues, improving glycogen synthesis in liver, restoring pancreatic islets dysfunction, slowing gastric emptying rates, and improving diabetic renal and brain disorders. Cinnamaldehyde exerts these effects through its action on multiple signaling pathways, including PPARs, AMPK, PI3K/IRS-1, RBP4-GLUT4, and ERK/JNK/p38MAPK, TRPA1-ghrelin and Nrf2 pathways. In addition, cinnamaldehyde seems to regulate the activities of PTP1B and alpha-amylase. Furthermore, cinnamaldehyde has the potential of metalizing into cinnamyl alcohol and methyl cinnamate and cinnamic acid in the body. Finally, there is a potential toxicity concern about this compound. In summary, cinnamaldehyde supplementation is shown to improve glucose and lipid homeostasis in diabetic animals, which may provide a new option for diabetic intervention. To this end, further scientific evidences are required from clinical trials on its glucose regulating effects and safety. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:78 / 89
页数:12
相关论文
共 122 条
  • [51] Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
    Juellig, Mia
    Yip, Shelley
    Xu, Aimin
    Smith, Greg
    Middleditch, Martin
    Booth, Michael
    Babor, Richard
    Beban, Grant
    Murphy, Rinki
    [J]. PLOS ONE, 2014, 9 (05):
  • [52] Karrow N A, 2001, Am J Contact Dermat, V12, P6, DOI 10.1053/ajcd.2001.0120006
  • [53] Cinnamaldehyde supplementation prevents fasting-induced hyperphagia, lipid accumulation, and inflammation in high-fat diet-fed mice
    Khare, Pragyanshu
    Jagtap, Sneha
    Jain, Yachna
    Baboota, Ritesh K.
    Mangal, Priyanka
    Boparai, Ravneet K.
    Bhutani, Kamlesh K.
    Sharma, Shyam S.
    Premkumar, Louis S.
    Kondepudi, Kanthi K.
    Chopra, Kanwaljit
    Bishnoi, Mahendra
    [J]. BIOFACTORS, 2016, 42 (02) : 201 - 211
  • [54] All (C57BL/6) mice are not created equal
    Kiselycznyk, Carly
    Holmes, Andrew
    [J]. FRONTIERS IN NEUROSCIENCE, 2011, 5
  • [55] Diminished Acyl-CoA Synthetase Isoform 4 Activity in INS 832/13 Cells Reduces Cellular Epoxyeicosatrienoic Acid Levels and Results in Impaired Glucose-stimulated Insulin Secretion
    Klett, Eric L.
    Chen, Shufen
    Edin, Matthew L.
    Li, Lei O.
    Ilkayeva, Olga
    Zeldin, Darryl C.
    Newgard, Christopher B.
    Coleman, Rosalind A.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (30) : 21618 - 21629
  • [56] Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: Sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy
    Koivisto, Ari
    Hukkanen, Mika
    Saarnilehto, Marja
    Chapman, Hugh
    Kuokkanen, Katja
    Wei, Hong
    Viisanen, Hanna
    Akerman, Karl E.
    Lindstedt, Ken
    Pertovaara, Antti
    [J]. PHARMACOLOGICAL RESEARCH, 2012, 65 (01) : 149 - 158
  • [57] Effects of the polyphenol content on the anti-diabetic activity of Cinnamomum zeylanicum extracts
    Krishnakumar, I. M.
    Issac, Abin
    Johannah, N. M.
    Ninan, Eapen
    Maliakel, Balu
    Kuttan, Ramadassan
    [J]. FOOD & FUNCTION, 2014, 5 (09) : 2208 - 2220
  • [58] GC-MS analysis and screening of antidiabetic, antioxidant and hypolipidemic potential of Cinnamomum tamala oil in streptozotocin induced diabetes mellitus in rats
    Kumar, Suresh
    Vasudeva, Neeru
    Sharma, Sunil
    [J]. CARDIOVASCULAR DIABETOLOGY, 2012, 11
  • [59] TonEBP suppresses adipogenesis and insulin sensitivity by blocking epigenetic transition of PPARγ2
    Lee, Jun Ho
    Lee, Hwan Hee
    Ye, Byeong Jin
    Lee-Kwon, Whaseon
    Choi, Soo Youn
    Kwon, Hyug Moo
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [60] Chemical Composition and Hypoglycemic and Pancreas-Protective Effect of Leaf Essential Oil from Indigenous Cinnamon (Cinnamomum osmophloeum Kanehira)
    Lee, Shih-Chieh
    Xu, Wen-Xin
    Lin, Li-Yun
    Yang, Jia-Jung
    Liu, Cheng-Tzu
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2013, 61 (20) : 4905 - 4913